Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

Giamarellos-Bourboulis E, Tang J, Pyleris E, Pistiki A, Barbatzas C, Brown J, Lee CC, Harkins TT, Kim G, Weitsman S, Barlow GM, Funari VA, Pimentel M.

Scand J Gastroenterol. 2015 Apr 11:1-12. [Epub ahead of print]

PMID:
25865706
2.

[Small intestinal bacterial overgrowth as a cause of lactase deficiency].

[No authors listed]

Ter Arkh. 2015;87(2):20-3. Russian.

PMID:
25864343
3.

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.

Lopetuso LR, Scaldaferri F, Bruno G, Petito V, Franceschi F, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2015 Mar;19(6):1068-76.

4.

Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO.

Miazga A, Osiński M, Cichy W, Żaba R.

Adv Med Sci. 2015 Mar;60(1):118-124. doi: 10.1016/j.advms.2014.09.001. Epub 2014 Oct 6. Review.

PMID:
25657082
5.

Diagnostic modalities for the evaluation of small bowel disorders.

Kopylov U, Seidman EG.

Curr Opin Gastroenterol. 2015 Mar;31(2):111-7. doi: 10.1097/MOG.0000000000000159.

PMID:
25635667
6.

Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran.

Abbasi MH, Zahedi M, Darvish Moghadam S, Shafieipour S, HayatBakhsh Abbasi M.

Middle East J Dig Dis. 2015 Jan;7(1):36-40.

7.

Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.

Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.

Rom J Intern Med. 2014;52(3):143-50.

PMID:
25509557
8.

Small intestinal bacterial overgrowth is an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhoea-predominant irritable bowel syndrome in Asia.

Wang Y, Xiong L, Gong X, Li W, Zhang X, Chen M.

J Gastroenterol Hepatol. 2014 Dec 3. doi: 10.1111/jgh.12862. [Epub ahead of print]

PMID:
25470082
9.

Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.

Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, Chua KS, Srinivasan S, Barlow GM, Chang C.

Dig Dis Sci. 2014 Nov 26. [Epub ahead of print]

PMID:
25424202
10.

Glucose hydrogen breath test for small intestinal bacterial overgrowth in children with abdominal pain-related functional gastrointestinal disorders.

Korterink JJ, Benninga MA, van Wering HM, Deckers-Kocken JM.

J Pediatr Gastroenterol Nutr. 2015 Apr;60(4):498-502. doi: 10.1097/MPG.0000000000000634.

PMID:
25406525
11.

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Boltin D, Perets TT, Shporn E, Aizic S, Levy S, Niv Y, Dickman R.

Ann Clin Microbiol Antimicrob. 2014 Oct 17;13:49. doi: 10.1186/s12941-014-0049-x.

12.

Hydrogen breath tests in gastrointestinal diseases.

Rana SV, Malik A.

Indian J Clin Biochem. 2014 Oct;29(4):398-405. doi: 10.1007/s12291-014-0426-4. Epub 2014 Mar 21. Review.

PMID:
25298621
13.

An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Slim M, Calandre EP, Rico-Villademoros F.

Rheumatol Int. 2015 Mar;35(3):433-44. doi: 10.1007/s00296-014-3109-9. Epub 2014 Aug 14.

PMID:
25119830
14.

Associations between IL-1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India.

Srivastava D, Ghoshal U, Mittal RD, Ghoshal UC.

Neurogastroenterol Motil. 2014 Oct;26(10):1408-16. doi: 10.1111/nmo.12399. Epub 2014 Jul 30.

PMID:
25073651
15.

Breath tests and irritable bowel syndrome.

Rana SV, Malik A.

World J Gastroenterol. 2014 Jun 28;20(24):7587-601. doi: 10.3748/wjg.v20.i24.7587. Review.

16.

[Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].

Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A.

Pol Merkur Lekarski. 2014 May;36(215):307-10. Polish.

PMID:
24964506
17.

Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study.

Melchior C, Gourcerol G, Déchelotte P, Leroi AM, Ducrotté P.

United European Gastroenterol J. 2014 Apr;2(2):131-7. doi: 10.1177/2050640614521124.

18.

Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.

Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE.

Glob Adv Health Med. 2014 May;3(3):16-24. doi: 10.7453/gahmj.2014.019.

PMID:
24891990
19.

Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.

Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA.

Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):96-134. doi: 10.1016/j.rgmx.2014.01.004. Epub 2014 May 23. English, Spanish.

20.

Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.

Ghoshal UC, Srivastava D, Ghoshal U, Misra A.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.

PMID:
24849768
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk